---
provider: perplexity
model: sonar-deep-research
cached: false
start_time: '2025-12-01T18:13:32.076762'
end_time: '2025-12-01T18:16:02.577241'
duration_seconds: 150.5
template_file: templates/rule_research.md
template_variables:
  rule_id: ARBA00047239
  rule_type: arba
  go_terms: GO:0032206 (positive regulation of telomere maintenance)
  conditions_summary: '**Condition Set 1:** InterPro id: Chaperonin TCP-1, conserved
    site (InterPro:IPR002194) AND InterPro id: Thermosome subunit alpha (InterPro:IPR054827)
    AND taxon: Primates (NCBITaxon:9443)


    **Condition Set 2:** FunFam id: Telomeric repeat-binding factor 2 (CATH.FunFam:1.10.10.60:FF:000129)
    AND FunFam id: Telomeric repeat-binding factor 2 (CATH.FunFam:1.25.40.210:FF:000002)
    AND taxon: Mammalia (NCBITaxon:40674)


    **Condition Set 3:** FunFam id: Serine-protein kinase ATM (CATH.FunFam:1.10.1070.11:FF:000011)
    AND FunFam id: Serine-protein kinase ATM (CATH.FunFam:3.30.1010.10:FF:000015)
    AND taxon: Eukaryota (NCBITaxon:2759)


    **Condition Set 4:** FunFam id: Poly [ADP-ribose] polymerase (CATH.FunFam:1.10.150.50:FF:000012)
    AND FunFam id: Poly [ADP-ribose] polymerase (CATH.FunFam:1.25.40.20:FF:000009)
    AND taxon: Primates (NCBITaxon:9443)


    **Condition Set 5:** FunFam id: T-complex protein 1 subunit eta (CATH.FunFam:1.10.560.10:FF:000017)
    AND FunFam id: T-complex protein 1 subunit eta (CATH.FunFam:1.10.560.10:FF:000045)
    AND taxon: Haplorrhini (NCBITaxon:376913)


    **Condition Set 6:** FunFam id: Regulator of telomere elongation helicase 1 (CATH.FunFam:1.20.1160.20:FF:000006)
    AND FunFam id: Regulator of telomere elongation helicase 1 (CATH.FunFam:1.20.1160.20:FF:000009)
    AND FunFam id: Regulator of telomere elongation helicase 1 (CATH.FunFam:3.40.50.300:FF:000431)


    **Condition Set 7:** FunFam id: Mitogen-activated protein kinase (CATH.FunFam:1.10.510.10:FF:000624)
    AND taxon: Homo (NCBITaxon:9605)


    **Condition Set 8:** FunFam id: RuvB-like helicase (CATH.FunFam:1.10.8.60:FF:000010)
    AND taxon: Mus (NCBITaxon:862507)


    **Condition Set 9:** FunFam id: SLX4 structure-specific endonuclease subunit (CATH.FunFam:3.30.710.10:FF:000116)
    AND taxon: Metazoa (NCBITaxon:33208)


    *These condition sets are OR-ed together (any match triggers the annotation)*'
  protein_count: 0 total (0 reviewed, 0 unreviewed)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    reasoning_effort: medium
    search_domain_filter: []
    return_citations: true
    temperature: 0.0
citation_count: 59
---

## Question

# UniProt Rule Research

## Rule Context

- **Rule ID:** ARBA00047239
- **Rule Type:** arba
- **GO Term(s) Predicted:** GO:0032206 (positive regulation of telomere maintenance)
- **Proteins Annotated:** 0 total (0 reviewed, 0 unreviewed)

### Condition Summary

**Condition Set 1:** InterPro id: Chaperonin TCP-1, conserved site (InterPro:IPR002194) AND InterPro id: Thermosome subunit alpha (InterPro:IPR054827) AND taxon: Primates (NCBITaxon:9443)

**Condition Set 2:** FunFam id: Telomeric repeat-binding factor 2 (CATH.FunFam:1.10.10.60:FF:000129) AND FunFam id: Telomeric repeat-binding factor 2 (CATH.FunFam:1.25.40.210:FF:000002) AND taxon: Mammalia (NCBITaxon:40674)

**Condition Set 3:** FunFam id: Serine-protein kinase ATM (CATH.FunFam:1.10.1070.11:FF:000011) AND FunFam id: Serine-protein kinase ATM (CATH.FunFam:3.30.1010.10:FF:000015) AND taxon: Eukaryota (NCBITaxon:2759)

**Condition Set 4:** FunFam id: Poly [ADP-ribose] polymerase (CATH.FunFam:1.10.150.50:FF:000012) AND FunFam id: Poly [ADP-ribose] polymerase (CATH.FunFam:1.25.40.20:FF:000009) AND taxon: Primates (NCBITaxon:9443)

**Condition Set 5:** FunFam id: T-complex protein 1 subunit eta (CATH.FunFam:1.10.560.10:FF:000017) AND FunFam id: T-complex protein 1 subunit eta (CATH.FunFam:1.10.560.10:FF:000045) AND taxon: Haplorrhini (NCBITaxon:376913)

**Condition Set 6:** FunFam id: Regulator of telomere elongation helicase 1 (CATH.FunFam:1.20.1160.20:FF:000006) AND FunFam id: Regulator of telomere elongation helicase 1 (CATH.FunFam:1.20.1160.20:FF:000009) AND FunFam id: Regulator of telomere elongation helicase 1 (CATH.FunFam:3.40.50.300:FF:000431)

**Condition Set 7:** FunFam id: Mitogen-activated protein kinase (CATH.FunFam:1.10.510.10:FF:000624) AND taxon: Homo (NCBITaxon:9605)

**Condition Set 8:** FunFam id: RuvB-like helicase (CATH.FunFam:1.10.8.60:FF:000010) AND taxon: Mus (NCBITaxon:862507)

**Condition Set 9:** FunFam id: SLX4 structure-specific endonuclease subunit (CATH.FunFam:3.30.710.10:FF:000116) AND taxon: Metazoa (NCBITaxon:33208)

*These condition sets are OR-ed together (any match triggers the annotation)*

---

## Research Objective

This is a UniProt annotation rule that predicts GO terms based on protein domain/family signatures. Your task is to evaluate whether this rule makes valid biological predictions based on what is known about the relevant domains and families, their structure, and conservation.

In an ideal case, you will be able to find literature that speaks specifically to the relationship between domains/families and
the function. Failing that, include what is known specifically about other functions that domains/families have, as well what domains/
families are known for the function.

## Research Questions

### 1. Domain/Signature Context

For each domain signature in this rule:
- What is the biological function of proteins containing this domain?
- Is this domain diagnostic for the predicted function?
- Are there known subfamilies with different functions?
- Is the domain or family known to be multifunctional, are there known cases of neofunctionalization?

### 2. GO Term Appropriateness

For the predicted GO term(s) **GO:0032206 (positive regulation of telomere maintenance)**:
- Is this GO term appropriate for proteins matching these conditions?
- Is the term too broad? (e.g., "catalytic activity" when a more specific term exists)
- Is the term too narrow? (e.g., a specific substrate when the domain covers broader specificity)
- Are there better alternative GO terms?

### 3. Literature Support

- What experimental evidence supports this functional annotation?
- Are there key papers describing this protein family/enzyme?
- Are there any contradictory findings in the literature?
- Is this a well-established function or more speculative?

### 4. Taxonomic Considerations

If this rule has taxonomic restrictions:
- Is the function conserved across the taxa included?
- Are there taxa that should be excluded (different function)?
- Are there taxa that could be included but are currently excluded?

### 5. Rule Logic Assessment

- Do the domain combinations make biological sense?
- Are there redundant conditions that could be removed?
- Could false positives arise from these conditions?

## Output Format

Please provide your findings in a narrative format with citations. Structure your response as:

1. **Executive Summary** - Brief assessment of rule validity
2. **Domain Analysis** - What each domain/signature represents
3. **GO Term Evaluation** - Assessment of the predicted annotation
4. **Evidence Review** - Key literature supporting or contradicting the rule
5. **Recommendations** - Suggested improvements or concerns

Be sure to include citations for all statements.

## Output

<think>
This is a complex query asking me to evaluate a UniProt annotation rule (ARBA00047239) that predicts the GO term GO:0032206 (positive regulation of telomere maintenance) based on various domain signatures and FunFam conditions. Let me break down the search results I have to understand what I can work with:

From the search results, I have information about:
1. Telomere maintenance and telomere-binding proteins
2. The shelterin complex components (TERF1, TERF2, POT1, TIN2, RAP1, TPP1)
3. TRiC/CCT complex and its role in telomerase trafficking
4. PARP proteins and their role in telomere maintenance
5. RTEL1 and its role in telomere maintenance
6. ATM kinase and DNA damage response
7. Alternative lengthening of telomeres (ALT)
8. SLX4 and its role in telomere function
9. RIOK2 and telomere maintenance

The rule has 9 condition sets that are OR-ed together. Let me analyze each:

1. TCP1 chaperonin + thermosome subunit alpha + Primates
2. TERF2 FunFams + Mammalia
3. ATM FunFams + Eukaryota
4. PARP FunFams + Primates
5. T-complex protein 1 subunit eta + Haplorrhini
6. RTEL1 FunFams
7. MAPK + Homo
8. RuvB-like helicase + Mus
9. SLX4 + Metazoa

Now I need to write a comprehensive report evaluating whether these conditions appropriately predict GO:0032206 (positive regulation of telomere maintenance).

Let me organize my findings:

Key findings from the search results:
- TRiC/CCT (which includes TCP1 subunits) mediates folding of TCAB1, which is essential for telomerase trafficking and telomere maintenance [26][29][47]


- TERF2 functions as a core component of the shelterin complex responsible for telomere protection [6][32][33][35]
- ATM responds to uncapped telomeres and coordinates DNA damage signaling at chromosome ends [25][50]
- PARP enzymes regulate telomere stability and maintenance pathways [14][17]
- RTEL1 facilitates telomere replication and maintenance processes [15][18]
- SLX4 participates in telomere recombination and resolution [37][40]
- MAPK signaling can modulate telomerase activity [23]
- RuvB-like helicases contribute to DNA processing functions

Now I need to evaluate whether these nine condition sets form a coherent and accurate rule for predicting positive regulation of telomere maintenance.
</think>

# Comprehensive Evaluation of UniProt Rule ARBA00047239 for Positive Regulation of Telomere Maintenance (GO:0032206)

This research report provides a detailed assessment of UniProt annotation rule ARBA00047239, which predicts the Gene Ontology term GO:0032206 (positive regulation of telomere maintenance) based on protein domain signatures and functional family classifications. The rule employs nine distinct condition sets that are combined with OR logic, each targeting different protein families and taxonomic groups potentially involved in telomere maintenance pathways. Our analysis reveals that while several conditions have strong biological support, others require clarification regarding their direct roles in positive telomere regulation, and the overall rule structure presents both opportunities for refinement and legitimate concerns regarding specificity and potential false-positive annotations.

## Biological Context of Telomere Maintenance and Protein Quality Control

### The Telomere Maintenance Pathway and Its Regulators

Telomeres represent specialized nucleoprotein structures located at chromosome termini that serve critical protective functions against chromosome fusion, degradation, and loss of genetic information[3]. In humans, telomeric sequences are composed of repetitive TTAGGG sequences that provide protection and facilitate replication of chromosome ends to prevent degradation[6]. The maintenance of telomere structure and length requires a complex interplay of multiple protein complexes and enzymatic activities, each contributing distinct functions to preserve genomic integrity and prevent premature cellular senescence.

The primary mechanism for telomere maintenance in most human cell types involves telomerase, a specialized ribonucleoprotein enzyme that adds new telomeric repeats to chromosome ends[5][26]. However, this process is tightly regulated through multiple hierarchical control mechanisms, including transcriptional regulation of telomerase components, post-translational modifications, subcellular localization, and recruitment to telomeres[26][29]. In addition to telomerase-dependent maintenance, a subset of cancer cells and immortalized cell lines utilize alternative lengthening of telomeres (ALT), a recombination-mediated mechanism that maintains telomeric length through homologous recombination-driven DNA replication[37][52].

The **shelterin complex** represents the primary protective machinery at mammalian telomeres, comprising six subunits: TERF1, TERF2, POT1, TIN2, RAP1, and TPP1[6][32]. This complex recognizes telomeric TTAGGG sequences and generates specialized T-loop structures that cap chromosome ends and prevent activation of DNA damage response pathways[6][32][35]. Beyond the shelterin complex, numerous auxiliary proteins contribute to telomere maintenance, including DNA repair factors, recombination proteins, helicases, and chaperone complexes that facilitate proper protein folding and assembly of telomeric components[26][29][47].

### Protein Quality Control Systems and Telomere Biology

The chaperonin TRiC/CCT complex (T-complex protein 1 ring complex, also known as chaperonin-containing TCP-1 complex) represents a critical molecular chaperone system that assists in the folding of diverse cellular proteins, including numerous obligate substrates essential for telomere maintenance[7][26][29]. Comprising eight distinct subunits (CCT1-CCT8), TRiC functions through an ATP-dependent mechanism to fold nascent polypeptides in a specialized central cavity, ensuring proper protein conformation and enabling subsequent assembly of functional complexes[7][26]. Recent evidence has established that TRiC plays an absolutely essential role in the telomerase trafficking pathway, specifically through mediation of TCAB1 (telomerase Cajal body protein 1) folding, which controls trafficking of the telomerase RNA component (TERC) and small Cajal body RNAs to Cajal bodies where telomerase holoenzyme assembly occurs[26][29][47].

## Analysis of Individual Domain Signatures in Rule ARBA00047239

### Condition Set 1: TCP1/Thermosome Chaperonin Complex in Primates

**Domain Signatures:** Chaperonin TCP-1 conserved site (InterPro:IPR002194) AND Thermosome subunit alpha (InterPro:IPR054827) with taxonomic restriction to Primates (NCBITaxon:9443)

The TCP1 chaperonin represents a core component of the TRiC complex, functioning as a molecular chaperone essential for folding numerous obligate substrate proteins[10][26]. The thermosome subunit alpha designation (IPR054827) refers to the archaeal homolog of TCP1, indicating conserved structural and functional relationships across domains of life. The strong biological rationale for this condition derives from recent discoveries establishing that TRiC mediates folding of TCAB1, a protein absolutely required for trafficking of telomerase to Cajal bodies and maintenance of telomere length[26][29][47].

Recent research provides compelling experimental evidence that depletion of any TRiC subunit results in loss of TCAB1 protein accumulation and mislocalization of telomerase from Cajal bodies to nucleoli, leading to complete failure of telomere elongation[29]. Furthermore, dyskeratosis congenita (DC), a severe stem cell disease characterized by short telomeres and bone marrow failure, is caused in certain cases by mutations in TCAB1 that specifically disrupt its folding by TRiC[29][47]. These mutations markedly increase association of TCAB1 with TRiC but significantly reduce binding to TERC, disrupting telomerase function and causing severe disease[44][47]. The genetic evidence from human disease thus strongly validates the direct involvement of TRiC-mediated protein folding in telomere maintenance pathways.

The taxonomic restriction to Primates in this condition set merits closer examination. The research results indicate that TRiC's role in TCAB1 folding appears broadly conserved across mammalian species and likely across eukaryotes more generally[29][47]. Telomere maintenance requirements exist across all eukaryotic lineages, and the core mechanisms of telomerase trafficking and assembly through chaperone assistance would be expected to operate similarly across vertebrate classes. The restriction to Primates therefore appears unnecessarily narrow and may exclude valid ortholog annotations in other mammalian groups that harbor TCAB1 mutations causing analogous telomere disease states.

However, the functional assessment is clearly positive: TCP1-containing chaperonin complexes demonstrably promote positive regulation of telomere maintenance through their essential role in enabling telomerase trafficking and assembly. This condition set represents strong biological support for the predicted GO term.

### Condition Set 2: Telomeric Repeat-Binding Factor 2 (TERF2) FunFams in Mammalia

**Domain Signatures:** CATH.FunFam:1.10.10.60:FF:000129 (TERF2) AND CATH.FunFam:1.25.40.210:FF:000002 (TERF2) with taxonomic restriction to Mammalia (NCBITaxon:40674)

TERF2 (telomeric repeat-binding factor 2) represents a core component of the shelterin protective complex and is one of two primary double-stranded DNA-binding proteins that recognize telomeric TTAGGG repeat sequences[6][32][35]. TERF2 carries a similar structure to TERF1, including a C-terminus Myb motif and large TERF homology domain near the N-terminus, but maintains distinct functions through possession of a basic N-terminal domain rather than the acidic domain found in TERF1[35]. The recognition that TERF2 contains multiple CATH FunFam representatives reflects the structural complexity and multifaceted functional roles of this protein.

The biological functions of TERF2 directly support classification as a positive regulator of telomere maintenance through multiple mechanisms. First, TERF2 plays a central role in promoting T-loop formation by preferentially binding to telomeric double-stranded DNA duplexes containing 3' TTAGGG single-stranded overhangs, then migrating to the t-loop junction where the single-stranded overhang invades the double-stranded region[35]. This structural remodeling effectively caps chromosome ends and prevents recognition by cellular DNA repair machinery as double-strand breaks. Second, TERF2 blocks ATM kinase DNA damage response signaling at telomeres through a mechanism believed to involve crosslinking ATM monomers and maintaining the kinase in its inactive dimeric state[35]. Third, TERF2 interacts directly with the TERT gene promoter in a telomere length-sensitive manner to regulate telomerase expression through recruitment of epigenetic repressor complexes, establishing a feedback mechanism wherein shortened telomeres release TRF2 from telomeres to suppress TERT expression, while lengthened telomeres sequester TRF2 away from the TERT promoter to permit high telomerase expression[33].

The evidence for TERF2's role in positive regulation of telomere maintenance is exceptionally strong from both structural and genetic perspectives. TERF2 deletion or functional impairment leads to loss of T-loop formation, excessive telomeric DNA degradation, and degradation of telomeric 3' overhangs through excision repair exonuclease ERCC1/XPF activity[6][35]. The requirement for TERF2 stability through cooperative interactions with TERF1 and TIN2 further demonstrates the integration of TERF2 function within broader telomere protective machinery[32][35].

However, a nuanced consideration arises regarding the classification of TERF2 as a "positive" regulator of telomere maintenance. TERF2 functions primarily as a negative regulator of telomere lengthening and as a protective factor preventing inappropriate DNA damage signaling rather than as an active promoter of telomere extension[35][36]. The distinction between telomere maintenance (preservation of existing telomere length and structure) versus telomere lengthening (active extension of telomere sequences) becomes semantically important here. TERF2 maintains telomeres through preventing their degradation and inappropriate replication, which represents maintenance rather than positive regulation in the sense of active promotion. This observation suggests that while TERF2 is essential for telomere preservation, it may not strictly satisfy the definition of "positive regulation" which typically implies active upregulation or promotion rather than passive protection.

### Condition Set 3: Ataxia Telangiectasia Mutated Kinase (ATM) FunFams in Eukaryota

**Domain Signatures:** CATH.FunFam:1.10.1070.11:FF:000011 (ATM) AND CATH.FunFam:3.30.1010.10:FF:000015 (ATM) with taxonomic restriction to Eukaryota (NCBITaxon:2759)

ATM (ataxia telangiectasia mutated) represents a serine/threonine protein kinase belonging to the phosphatidylinositol 3-kinase-like kinase (PIKK) family that functions as a central hub in cellular responses to DNA damage[25][50]. ATM is activated by DNA double-strand breaks through an autophosphorylation mechanism at serine 1981, with the activated monomer subsequently phosphorylating multiple downstream effector proteins involved in cell cycle checkpoints, DNA repair, and apoptosis[25][50].

The relationship between ATM kinase activity and telomere maintenance presents considerable complexity and context-dependency. When telomeres become dysfunctional due to shortening, inappropriate deprotection, or uncapping through loss of shelterin components, ATM kinase activation occurs at chromosome ends, triggering DNA damage responses analogous to double-strand break responses[25][35]. This leads to recruitment of damage response factors including H2AFX and 53BP1, and ultimately to ATM-dependent phosphorylation of p53 to trigger cell cycle arrest and apoptosis[35][50]. From this perspective, ATM activity at dysfunctional telomeres represents a negative regulator of telomere maintenance through induction of senescence or apoptosis.

However, ATM also plays essential roles in promoting DNA repair and homologous recombination at telomeres[25][51][53]. ATM phosphorylates CtIP, which is required for DNA end resection and initiation of homologous recombination repair of double-strand breaks[25]. Furthermore, ATM-dependent checkpoint signaling and p53 activation represent critical mechanisms for preventing proliferation of cells with critically short telomeres, thereby suppressing telomere-dependent carcinogenesis[53]. The protective role of ATM in preventing inappropriate telomere-driven tumorigenesis could be conceptualized as a form of "positive regulation" of telomere biology by maintaining genomic stability and preventing cancer development.

The designation of ATM as a positive regulator of telomere maintenance appears problematic and potentially misleading. The primary acute effects of ATM activation at telomeres involve triggering senescence or apoptosis in cells with dysfunctional telomeres, which represents suppression rather than promotion of telomere maintenance. While ATM's role in DNA damage checkpoint responses provides longer-term organismal benefits through cancer prevention, this represents an indirect and contextually-dependent relationship to telomere maintenance rather than direct positive regulation. The eukaryotic taxonomic scope appears appropriate given that ATM orthologs function similarly across eukaryotic lineages, but the functional classification warrants reconsideration.

### Condition Set 4: Poly(ADP-ribose) Polymerase (PARP) FunFams in Primates

**Domain Signatures:** CATH.FunFam:1.10.150.50:FF:000012 (PARP) AND CATH.FunFam:1.25.40.20:FF:000009 (PARP) with taxonomic restriction to Primates (NCBITaxon:9443)

The PARP protein family comprises multiple members with distinct roles in DNA damage response and telomere maintenance. PARP1, PARP2, and PARP3 function primarily in DNA repair through poly(ADP-ribose) transferase activity that catalyzes synthesis of branched PAR polymers utilizing NAD+ as substrate[14][17]. Tankyrases 1 and 2 represent specialized PARP family members particularly implicated in telomere function and ALT pathway regulation[14].

PARP1 demonstrates direct involvement in telomere maintenance through multiple mechanisms. Recent research indicates that PARP1 regulates telomerase complex assembly and activity through poly(ADP-ribosyl)ation of telomerase complex components DKC1 and GAR1, which are H/ACA RNA-binding proteins involved in telomerase maturation and activity[17]. Cells with decreased PARP1 levels demonstrate increased telomerase activity coupled with abnormal telomere dynamics[17]. Furthermore, PARP1 participates in regulating TRF2 binding and localization at telomeres, thereby influencing telomere shortening rates[17].

PARP3 appears particularly important for telomere maintenance in the context of ALT mechanisms. PARP3 knockdown in cultured cells spontaneously increases telomere loss and sister telomere fusions[14]. The cooperation between PARP3 and tankyrase 1 in regulating telomeric protein interactions further suggests layered regulation of telomere function by PARP family members[14].

The evidence supports PARP proteins as genuine positive regulators of telomere maintenance. The regulatory role of PARP1 in controlling telomerase assembly and activity, combined with its functions in maintaining proper TRF2 localization and protecting telomeres from damage, constitutes direct positive regulation of telomere length maintenance. The taxonomic restriction to Primates appears unnecessarily narrow, as PARP-mediated telomere regulation would be expected to operate broadly across mammalian species with active telomerase. PARP orthologs in other mammals should function similarly in telomere maintenance, suggesting the taxonomic scope should potentially be expanded to encompass Mammalia or other broader eukaryotic groups.

### Condition Set 5: T-Complex Protein 1 Subunit Eta FunFams in Haplorrhini

**Domain Signatures:** CATH.FunFam:1.10.560.10:FF:000017 (TCP1 eta) AND CATH.FunFam:1.10.560.10:FF:000045 (TCP1 eta) with taxonomic restriction to Haplorrhini (NCBITaxon:376913)

The T-complex protein 1 subunit eta (also designated as CCT2 when part of the CCT nomenclature system) represents one of eight subunits comprising the TRiC chaperonin complex. CCT2 has received particular attention due to its emerging role in modulating the formation of abnormal amyloid aggregates including amyloid beta, tau, and polyglutamine deposits central to neurodegenerative disease pathogenesis[7]. Recent evidence indicates neuroprotective roles for CCT2 in preventing protein aggregation pathology[7].

The specific involvement of TCP1 eta subunit in telomere maintenance parallels the general mechanism of TRiC involvement discussed in Condition Set 1. As a component of the TRiC complex, TCP1 eta participates in the folding of multiple substrate proteins, including TCAB1 and other telomerase-associated factors[29][47]. The existence of two separate FunFam entries for TCP1 eta (FF:000017 and FF:000045) potentially reflects functional specialization or subfamily distinctions within this protein, possibly corresponding to tissue-specific variants or functionally distinct contexts.

The biological rationale for this condition remains sound given TRiC's established role in telomerase trafficking and telomere maintenance. However, the restriction to Haplorrhini (dry-nosed primates) appears unnecessarily restrictive. The requirement for TRiC-mediated TCAB1 folding and telomerase trafficking would be expected to operate identically in other mammalian groups, including wet-nosed primates and other mammals. The selection of such a narrow taxonomic scope may reflect data availability limitations in the training sets used to generate this annotation rule rather than reflecting true biological constraints.

### Condition Set 6: Regulator of Telomere Elongation Helicase 1 (RTEL1) FunFams

**Domain Signatures:** CATH.FunFam:1.20.1160.20:FF:000006 (RTEL1) AND CATH.FunFam:1.20.1160.20:FF:000009 (RTEL1) AND CATH.FunFam:3.40.50.300:FF:000431 (RTEL1) without specific taxonomic restriction

RTEL1 (regulator of telomere elongation helicase 1) represents a DNA helicase first identified in mice as responsible for maintenance of long telomeres in embryonic stem cells[15][18]. RTEL1 maintains telomere integrity and genome stability through multiple distinct mechanisms, including removal of telomeric DNA unwinding structures and facilitation of replication fork progression[15].

The mechanisms by which RTEL1 promotes telomere maintenance include: resolution of telomeric G-quadruplex (G4) structures and unwinding of T-loops through helicase activity[15]; removal of displacement loops formed at the base of T-loops through cooperative action with TRF2 recruitment[15]; and promotion of mitotic DNA synthesis (MiDAS) at G4/R-loop forming loci including telomeres that remain under-replicated during interphase in response to replication stress[15]. In the absence of RTEL1, T-loops cannot be efficiently unwound during replication, leading to formation of reversed replication forks that become traps for telomerase, resulting in telomere loss and telomeric circle formation[15].

The evidence strongly supports RTEL1 as a positive regulator of telomere maintenance. RTEL1 mutations cause Hoyeraal-Hreidarsson syndrome (HHS), a severe form of dyskeratosis congenita characterized by short telomeres, developmental defects, bone marrow failure, and immunodeficiency[15][51]. The direct genetic evidence from human disease demonstrates that loss of RTEL1 function results in severe telomere shortening and failure of telomere maintenance, establishing RTEL1 as essential for proper telomere biology.

Notably, this condition set contains three separate FunFam entries without specific taxonomic restriction, suggesting that RTEL1 function in telomere maintenance may be broadly conserved across organisms. The absence of taxonomic constraints appears appropriate given the fundamental requirement for telomere maintenance across eukaryotes.

### Condition Set 7: Mitogen-Activated Protein Kinase (MAPK) in Homo (Humans)

**Domain Signatures:** CATH.FunFam:1.10.510.10:FF:000624 (MAPK) with taxonomic restriction to Homo (NCBITaxon:9605)

Mitogen-activated protein kinases represent an important family of protein kinases involved in transmitting signals from the cell membrane to the nucleus[23]. MAPKs including ERK1/2, p38, and JNK participate in diverse cellular processes including cell cycle regulation, differentiation, apoptosis, and stress responses[23][35].

The relationship between MAPK activity and telomere maintenance involves multiple layers of regulation. ERK1/2 has been identified as a mechanism for phosphorylating TERF2, a modification that functions as a controlling factor in pro-oncogenic signaling pathways affecting telomeric stability[35]. Furthermore, MAPK cascade-mediated histone H3 phosphorylation has been identified as linking cellular signaling to chromatin modifications at telomeres[20]. Recent research demonstrates that estrogen can induce telomerase activity through MAPK-dependent mechanisms[23].

However, the classification of MAPK as a positive regulator of telomere maintenance appears problematic. While MAPK signaling participates in regulation of telomerase and telomeric protein modifications, MAPK activation occurs in response to diverse cellular stimuli, many of which promote proliferation and cellular transformation rather than telomere maintenance per se. The relationship between MAPK activity and telomere length represents a complex context-dependent phenomenon rather than a direct regulatory mechanism. Furthermore, oncogenic MAPK signaling is associated with activation of immortalization pathways and acquisition of telomere maintenance mechanisms that drive cancer development, suggesting that sustained MAPK activation may promote telomere-dependent transformation rather than supporting normal telomere maintenance.

The restriction to human (Homo) appears unnecessarily limiting, as MAPK signaling mechanisms would be expected to function identically across mammalian species. The functional assignment of MAPK to positive telomere maintenance regulation warrants reconsideration given the indirect nature of the relationship and the complex context-dependency of MAPK effects on telomere biology.

### Condition Set 8: RuvB-like Helicase in Mus (Laboratory Mice)

**Domain Signatures:** CATH.FunFam:1.10.8.60:FF:000010 (RuvB-like helicase) with taxonomic restriction to Mus (NCBITaxon:862507)

RuvB-like helicases (RUVBL1 and RUVBL2) represent AAA+ ATPases that function in diverse cellular processes including nucleotide excision repair, homologous recombination, and transcriptional regulation[21][24]. RUVBL proteins possess DNA unwinding and helicase activities that function as components of larger protein complexes including the NuA4 histone acetyltransferase complex[24].

The biological relationship between RuvB-like helicases and telomere maintenance remains incompletely characterized. While RuvB-like proteins function in broader DNA repair and recombination processes that could theoretically impact telomere dynamics, specific direct involvement in positive regulation of telomere maintenance has not been clearly established in the search results provided. The absence of clear experimental evidence linking RuvB-like helicase activity to telomere length regulation represents a significant gap in the biological rationale for this condition set.

The restriction to laboratory mice (Mus) appears peculiar given that the telomere maintenance mechanisms would be expected to operate similarly across mammalian species. Notably, laboratory mice maintain exceptionally long telomeres and exhibit active telomerase in somatic tissues, properties that distinguish mouse telomere biology from human biology[58]. The restriction to Mus may reflect an attempt to avoid overgeneralization to species with different telomere dynamics, but without clear functional justification for restricting the annotation to this particular genus.

### Condition Set 9: SLX4 Structure-Specific Endonuclease Subunit in Metazoa

**Domain Signatures:** CATH.FunFam:3.30.710.10:FF:000116 (SLX4) with taxonomic restriction to Metazoa (NCBITaxon:33208)

SLX4 (structure-specific endonuclease subunit) functions as a regulatory subunit that interacts with and increases the activity of different structure-specific endonucleases including SLX1, ERCC4, and MUS81-EME1[22][37][40]. SLX4 plays important roles in DNA repair, particularly in processing of complex DNA structures including recombination intermediates and specialized replication fork structures[22].

Recent research has established direct involvement of SLX4 in telomere biology through regulation of recombination at ALT telomeres. SLX4 expression represses ALT-mediated telomere synthesis by promoting resolution of telomeric recombination intermediates after strand invasion[37]. Expression of SLX4 in ALT cells leads to suppression of inter-telomeric copying events, functioning as a counterbalance to BLM-mediated telomere extension[37]. Furthermore, SLX4 interacts with TERF2 through the TRFH domain, recruiting PARP1 to modulate telomere sister chromatid exchange and telomere length homeostasis[19][40].

The characterization of SLX4 as a positive regulator of telomere maintenance requires careful interpretation. In the context of ALT cells, SLX4 functions primarily to suppress telomere lengthening rather than promote it, suggesting a negative regulatory role in that specific context. However, in normal telomerase-proficient cells, SLX4's role in regulating telomeric recombination and maintaining proper chromosome segregation could support telomere homeostasis. The broad metazoan taxonomic scope appears appropriate given that telomere biology requirements exist across animal phyla, though the specific mechanisms may vary.

## Evaluation of GO Term GO:0032206 and Alternative Annotations

### Definition and Scope of GO:0032206

The Gene Ontology term GO:0032206 is defined as "positive regulation of telomere maintenance," with the parent term being "regulation of telomere maintenance" (GO:0032205)[1][2][4][5]. The distinction between GO:0032206 and related terms including GO:0032212 ("positive regulation of telomere maintenance via telomerase") and GO:0032200 ("telomere organization") represents important taxonomic distinctions within the Gene Ontology hierarchy of telomere-related biological processes[31][34].

The term "positive regulation" carries specific meaning within Gene Ontology, referring to processes that "activates or increases the frequency, rate or extent" of a regulated process[4][5]. Applied to telomere maintenance, positive regulation should encompass processes that upregulate, enhance, or promote maintenance of telomeric structure and length. This definition carries important implications for the appropriateness of various protein annotations.

### Appropriateness of Predicted Annotation for Each Condition Set

**TCP1/TRiC Complex (Condition Sets 1 and 5):** The assignment of TRiC components to GO:0032206 appears highly appropriate. TRiC directly enables telomere maintenance through mediation of TCAB1 folding, which is absolutely required for telomerase trafficking and assembly. This represents genuine positive regulation through enabling the assembly of the functional machinery responsible for telomere elongation[26][29][47]. The mechanism is direct, well-characterized, and essential.

**TERF2 (Condition Set 2):** The classification of TERF2 as a positive regulator of telomere maintenance presents semantic complexity. TERF2 functions primarily as a protective factor preventing telomere degradation and inappropriate DNA damage signaling rather than as an active promoter of telomere extension. While TERF2 is essential for telomere preservation and maintenance, it may be more accurately classified under GO:0000723 ("telomere maintenance") without the "positive regulation" qualifier, or under more specific terms like GO:0032205 ("regulation of telomere maintenance"). The feedback regulation of TERF2 on TERT expression represents indirect positive regulation that deserves consideration, but this effect manifests primarily in the context of short telomeres activating suppression of further extension.

**ATM Kinase (Condition Set 3):** The classification of ATM as a positive regulator of telomere maintenance appears inappropriate. ATM's primary acute effects at telomeres involve activation of DNA damage responses and induction of senescence or apoptosis, which suppress telomere-dependent cellular proliferation rather than promote telomere maintenance. While ATM's checkpoint functions provide organismal benefits through cancer prevention, this represents an indirect systemic effect rather than direct positive regulation of telomere biology. Alternative annotations such as GO:0006974 ("cellular response to DNA damage stimulus") would be more accurate for ATM's primary function.

**PARP Proteins (Condition Set 4):** The assignment of PARP proteins to GO:0032206 demonstrates strong biological support. PARP1 directly regulates telomerase complex assembly through PARylation of essential telomerase components, and PARP3 functions in maintaining proper telomeric recombination dynamics. These represent genuine positive regulatory functions in telomere maintenance[14][17].

**RTEL1 (Condition Set 6):** The classification of RTEL1 as a positive regulator of telomere maintenance receives strong support. RTEL1's helicase activity enables proper replication of telomeric sequences through resolution of G4 structures and T-loop unwinding, directly promoting telomere synthesis and maintenance[15]. This represents direct positive regulation essential for preventing telomere loss.

**MAPK (Condition Set 7):** The classification of MAPK as a positive regulator of telomere maintenance appears problematic. While MAPKs participate in signaling cascades that influence telomerase expression and telomeric protein modifications, these effects operate within complex contexts involving multiple regulatory inputs and potential opposing effects. The relationship lacks the directness and consistency expected for positive regulation annotation.

**RuvB-like Helicase (Condition Set 8):** The functional rationale for classifying RuvB-like helicases as positive regulators of telomere maintenance remains unclear from available evidence. Without specific documented mechanisms linking RuvB helicase activity to positive telomere regulation, this condition set appears weakly justified and potentially represents a false-positive annotation.

**SLX4 (Condition Set 9):** The classification of SLX4 as a positive regulator of telomere maintenance requires careful contextual consideration. In ALT cells, SLX4 suppresses telomere lengthening rather than promoting it. However, in normal cells, SLX4's regulation of telomeric recombination and its interaction with TERF2 in regulating telomere dynamics could support telomere homeostasis. The functional classification appears ambiguous and context-dependent.

### Alternative GO Terms with Greater Specificity

Several alternative Gene Ontology terms might provide more precise annotation for proteins in this rule set:

- **GO:0032212 ("positive regulation of telomere maintenance via telomerase"):** This term specifically encompasses positive regulation through telomerase mechanism and would be appropriate for proteins directly participating in telomerase assembly, trafficking, or activity enhancement. TRiC, TCAB1-binding proteins, and PARP1 could be appropriately annotated with this term.

- **GO:0000723 ("telomere maintenance"):** This broader term encompasses all processes contributing to telomere maintenance regardless of regulatory direction and would be appropriate for proteins like TERF2, RTEL1, and shelterin components that function in maintaining telomere structure and length through multiple mechanisms.

- **GO:0006974 ("cellular response to DNA damage stimulus"):** This term would appropriately capture ATM's primary function in sensing DNA damage and initiating checkpoint responses.

- **GO:0032200 ("telomere organization"):** This term encompasses processes involved in assembly, arrangement, or disassembly of telomeres and would be appropriate for proteins involved in telomeric chromatin structure and T-loop formation.

## Taxonomic Considerations and Conservation of Telomere Mechanisms

### Cross-Species Conservation of Telomere Biology

The fundamental requirement for telomere maintenance exists across eukaryotic lineages, and the core molecular mechanisms have been established to show remarkable conservation from yeast to humans[52][58]. The shelterin complex, telomerase enzyme, and associated helicases and recombination proteins maintain homologous relationships across metazoans, suggesting that the biological functions of these proteins would be expected to operate similarly across diverse taxa.

However, important species differences in telomere biology exist that warrant consideration. Laboratory mice maintain exceptionally long telomeres ranging from 40-200 kilobases compared to human telomeres of 5-15 kilobases, and mouse somatic tissues maintain active telomerase while humans typically express telomerase only in stem cell compartments[58]. These differences raise questions about whether regulation of telomerase and telomere length operates identically across species, potentially justifying differential taxonomic scopes for some annotation conditions.

### Assessment of Taxonomic Restrictions in Each Condition

**Primates (Condition Sets 1, 4):** The restriction to Primates appears unnecessarily narrow for both TCP1/TRiC and PARP proteins. The requirement for TRiC-mediated TCAB1 folding and for PARP-dependent regulation of telomerase assembly would be expected to operate broadly across mammals and potentially across vertebrates. The taxonomic restriction may reflect training data limitations rather than true biological constraints.

**Mammalia (Condition Set 2):** The restriction of TERF2 annotation to Mammalia appears appropriate, given that shelterin complex composition and function have been most extensively characterized in mammalian systems. However, TERF2 orthologs function similarly in other vertebrate classes, suggesting the scope could reasonably be expanded to Vertebrata or Chordata.

**Eukaryota (Condition Set 3):** The broad eukaryotic scope for ATM reflects the conservation of ATM-mediated checkpoint signaling across eukaryotic lineages, though the specific effects on telomere dynamics may vary substantially between species with active versus inactive telomerase in somatic tissues.

**Haplorrhini (Condition Set 5):** The restriction of TCP1 eta to dry-nosed primates appears unnecessarily restrictive. The telomere maintenance requirement exists identically in wet-nosed primates and other mammals, and the TRiC-mediated TCAB1 folding mechanism would be expected to operate similarly across all mammalian groups.

**No Taxonomic Restriction (Condition Set 6):** The absence of taxonomic restriction for RTEL1 appears appropriate given the fundamental conservation of this helicase's role in telomere maintenance across eukaryotes.

**Homo (Condition Set 7):** The restriction of MAPK annotation to human represents an extremely narrow scope, poorly justified given that MAPK signaling operates identically across mammalian species. The potential for overgeneralization seems minimal given that MAPK involvement in telomerase regulation has been documented in multiple species.

**Mus (Condition Set 8):** The restriction of RuvB-like helicase annotation to laboratory mice appears arbitrary, potentially reflecting peculiarities in the training data rather than true functional distinction from other mammals.

**Metazoa (Condition Set 9):** The broad metazoan taxonomic scope for SLX4 appears appropriate given the conservation of telomere biology across animal phyla.

## Examination of Rule Logic and Domain Combinations

### OR Versus AND Logic

The rule employs OR logic to combine nine distinct condition sets, meaning that a protein matching any single condition would receive the GO:0032206 annotation. This approach maximizes sensitivity for capturing all potential positive regulators of telomere maintenance but increases the risk of false-positive annotations, particularly for condition sets with weak or indirect biological support.

An alternative approach using AND logic (requiring multiple conditions to be satisfied simultaneously) would increase specificity and confidence in annotations but might miss valid telomere maintenance regulators that possess only a subset of the included domain signatures. The current OR approach appears to prioritize comprehensiveness over precision, which may be appropriate for exploratory annotation but warrants consideration of precision-specificity tradeoffs.

### Redundancy and Overlap Among Conditions

Several condition sets target overlapping biological functions. Condition Sets 1 and 5 both target TRiC components with slightly different taxonomic scopes, raising questions about whether both conditions are necessary or whether a single unified condition with appropriate taxonomic scope would suffice. Similarly, multiple conditions target different aspects of telomere protection and maintenance (TERF2, RTEL1, SLX4), potentially leading to redundant annotations of the same general functional category.

### Potential for False-Positive Annotations

Several condition sets carry elevated risk for false-positive annotations through multiple mechanisms. ATM kinase annotation may capture proteins involved primarily in DNA damage response rather than telomere maintenance per se. MAPK annotation may identify proteins primarily involved in cell signaling rather than direct telomere regulation. RuvB-like helicase annotation may incorrectly classify proteins involved in general DNA repair processes rather than telomere-specific functions. SLX4 annotation may misclassify proteins primarily involved in recombination resolution rather than positive telomere regulation, particularly in ALT-context cells.

## Key Literature Supporting and Contradicting the Rule

### Strong Supporting Evidence

The most robust experimental support exists for TRiC components and telomere maintenance. Multiple independent studies have demonstrated that depletion of any TRiC subunit results in loss of TCAB1 protein, mislocalization of telomerase, and failure of telomere elongation[26][29][47]. Genetic evidence from dyskeratosis congenita patients with TCAB1 mutations shows that these mutations specifically disrupt TRiC-mediated folding and cause disease through telomere maintenance failure[44][47]. This constitutes definitive experimental evidence supporting TRiC annotation.

RTEL1 evidence derives from genetic studies showing that constitutional RTEL1 mutations cause severe dyskeratosis congenita with profoundly short telomeres[51]. Multiple cellular and biochemical studies have demonstrated RTEL1's role in G4 unwinding, T-loop resolution, and telomere replication[15]. This provides strong genetic and molecular evidence for RTEL1 as a telomere maintenance factor.

PARP1 evidence includes demonstration that PARP1 regulates telomerase complex assembly and activity through PARylation of DKC1 and GAR1, with cells showing increased telomerase activity upon PARP1 depletion[17]. PARP1 also regulates TRF2 binding at telomeres, influencing telomere length homeostasis[17]. This provides direct biochemical evidence for PARP1 involvement in telomere maintenance regulation.

### Evidence Questioning the Rule

The ATM classification receives limited direct support as a positive telomere maintenance regulator. While ATM participates in DNA damage checkpoint responses, its acute effects at dysfunctional telomeres involve triggering senescence or apoptosis rather than promoting telomere maintenance[25][35][50][53]. The protective organismal-level effects of ATM in suppressing telomere-driven cancer represent indirect systemic benefits rather than direct positive regulation.

The MAPK classification receives weak support for direct telomere maintenance regulation. While MAPK signaling influences telomerase expression and TERF2 phosphorylation, these effects occur within complex signaling contexts involving multiple regulatory inputs[23][35]. The relationship lacks the directness expected for positive regulation.

The RuvB-like helicase classification receives minimal direct support. The search results provide no specific evidence linking RuvB helicase activity to positive regulation of telomere maintenance, raising questions about the biological rationale for this condition set.

## Recommendations for Rule Refinement

### Suggested Modifications to Improve Specificity and Biological Accuracy

**Priority 1 - Remove or Revise Weakly Supported Conditions:** Consider removing or substantially revising Condition Set 8 (RuvB-like helicase in Mus) given the lack of clear evidence linking RuvB helicase activity to direct telomere maintenance regulation. The restriction to laboratory mice appears particularly problematic and lacks clear biological justification.

**Priority 2 - Reconsider ATM Classification:** Condition Set 3 (ATM in Eukaryota) should be carefully reconsidered. ATM's primary function involves DNA damage sensing and checkpoint activation rather than positive regulation of telomere maintenance. If ATM annotation is retained, it should be qualified or restricted to specific contexts, or alternative GO terms such as GO:0006974 might be more appropriate.

**Priority 3 - Expand Taxonomic Scope:** Conditions restricted to narrow taxa (Primates, Haplorrhini, Homo, Mus) should be carefully evaluated for biological justification. Where justification appears weak, taxonomic scope should be expanded to encompass broader lineages. For example, TCP1/TRiC functions operate similarly across mammals and should not be restricted to Primates or Haplorrhini.

**Priority 4 - Clarify TERF2 and SLX4 Classifications:** The positive regulation classification for TERF2 and SLX4 should be carefully examined. TERF2 functions primarily as a protective factor rather than an active promoter of lengthening, while SLX4 effects vary contextually between ALT and non-ALT cells. Consider whether alternative GO terms like GO:0000723 (telomere maintenance) without the "positive" qualifier might be more accurate.

**Priority 5 - Consolidate Redundant Conditions:** Condition Sets 1 and 5 both target TRiC components. Consider consolidating these into a single condition with appropriate unified taxonomic scope rather than maintaining separate conditions with different taxonomic restrictions.

### Alternative GO Term Recommendations

Consider creating condition sets targeting more specific GO terms that might provide better functional precision:

- **GO:0032212 ("positive regulation of telomere maintenance via telomerase"):** This term would be highly appropriate for TRiC, PARP, and other proteins directly enhancing telomerase complex assembly or activity.

- **GO:0000723 ("telomere maintenance"):** This broader term would appropriately capture TERF2, shelterin components, and RTEL1 that maintain telomeres through protective and structural mechanisms rather than positive upregulation.

## Conclusion and Summary Assessment

The UniProt rule ARBA00047239 presents a comprehensive attempt to annotate proteins involved in positive regulation of telomere maintenance, incorporating nine distinct condition sets targeting major protein families known to participate in telomere biology. The rule demonstrates strong biological support for several conditions, particularly those targeting TRiC chaperonin components, RTEL1 helicase, and PARP proteins, which show clear direct involvement in promoting telomere maintenance through well-characterized mechanisms.

However, the rule exhibits several concerning features that warrant revision. Inclusion of ATM kinase as a positive telomere maintenance regulator appears problematic given ATM's primary acute function in activating DNA damage responses that suppress telomere-dependent proliferation. The RuvB-like helicase condition set lacks clear supporting evidence for direct telomere maintenance regulation. Several conditions employ unnecessarily narrow taxonomic restrictions that appear to reflect training data limitations rather than true biological constraints. The classification of TERF2 and SLX4 as positive regulators warrants reconsideration given their complex contextual roles in telomere biology.

The use of OR logic to combine these conditions maximizes sensitivity for capturing telomere maintenance regulators but increases the risk of false-positive annotations for proteins primarily involved in related but distinct biological processes such as general DNA damage response or recombination. Overall, the rule would benefit from revision to (1) remove or modify weakly supported conditions, (2) expand inappropriately narrow taxonomic scopes, (3) clarify functional roles of contextually-complex proteins like TERF2 and SLX4, and (4) consider whether alternative GO terms might provide better functional precision for certain protein families. Despite these limitations, the rule successfully captures several families with genuine involvement in positive telomere maintenance regulation, particularly TRiC chaperonin components whose role in telomerase trafficking has been thoroughly validated through genetic and biochemical evidence from both model organisms and human disease studies.

## Citations

1. https://amigo.geneontology.org/amigo/term/GO:0032206
2. https://amigo.geneontology.org/amigo/term/GO:0000723
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC4889915/
4. https://www.pombase.org/term/GO:0032206
5. https://maayanlab.cloud/Harmonizome/gene_set/telomere+maintenance/GO+Biological+Process+Annotations+2015
6. https://en.wikipedia.org/wiki/Telomere-binding_protein
7. https://pubmed.ncbi.nlm.nih.gov/40693240/
8. https://www.rcsb.org/annotations/1GN1
9. https://www.ncbi.nlm.nih.gov/gene/7014
10. https://www.uniprot.org/uniprotkb/P17987/entry
11. http://biogps.org/gene/6950/
12. https://www.uniprot.org/uniprotkb/Q15554/entry
13. https://www.cathdb.info/version/latest/funfam/1.25.10.10:FF:000010
14. https://pmc.ncbi.nlm.nih.gov/articles/PMC8964661/
15. https://pmc.ncbi.nlm.nih.gov/articles/PMC9875622/
16. https://www.uniprot.org/uniprotkb/Q13315/entry
17. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.621134/full
18. https://academic.oup.com/nar/article/43/3/1834/2411471
19. https://www.ncbi.nlm.nih.gov/gene/84464
20. https://pmc.ncbi.nlm.nih.gov/articles/PMC1317632/
21. https://www.ncbi.nlm.nih.gov/gene/8607
22. https://www.uniprot.org/uniprotkb/Q8IY92/entry
23. https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0055730
24. https://www.uniprot.org/uniprotkb/Q9Y265/entry
25. https://pmc.ncbi.nlm.nih.gov/articles/PMC8466060/
26. https://pmc.ncbi.nlm.nih.gov/articles/PMC10870801/
27. https://en.wikipedia.org/wiki/CCT6A
28. https://pmc.ncbi.nlm.nih.gov/articles/PMC196250/
29. https://pmc.ncbi.nlm.nih.gov/articles/PMC4329143/
30. https://www.ncbi.nlm.nih.gov/gene/908
31. https://amigo.geneontology.org/amigo/term/GO:0032212
32. https://pmc.ncbi.nlm.nih.gov/articles/PMC7617103/
33. https://elifesciences.org/articles/104045
34. https://www.informatics.jax.org/vocab/gene_ontology/GO:0032200
35. https://en.wikipedia.org/wiki/Telomeric_repeat-binding_factor_2
36. https://pmc.ncbi.nlm.nih.gov/articles/PMC5169358/
37. https://www.embopress.org/doi/10.15252/embj.201796889
38. https://pmc.ncbi.nlm.nih.gov/articles/PMC8150129/
39. https://www.uniprot.org/help/general_annota
40. https://pmc.ncbi.nlm.nih.gov/articles/PMC4499145/
41. https://www.cathdb.info/superfamily/1.25.40.720
42. https://www.uniprot.org/help/arba
43. https://pmc.ncbi.nlm.nih.gov/articles/PMC11695101/
44. https://www.nature.com/articles/s41467-024-51336-3
45. https://pmc.ncbi.nlm.nih.gov/articles/PMC8830517/
46. https://journals.plos.org/plosgenetics/article?id=10.1371%2Fjournal.pgen.1001342
47. https://nph.onlinelibrary.wiley.com/doi/10.1111/j.1469-8137.2012.04143.x
48. https://academic.oup.com/nar/article/51/17/9122/7230093
49. https://www.nature.com/articles/s12276-022-00863-4
50. https://pubmed.ncbi.nlm.nih.gov/23453664/
51. https://www.ncbi.nlm.nih.gov/books/NBK6486/
52. https://pmc.ncbi.nlm.nih.gov/articles/PMC1462967/
53. https://ashpublications.org/bloodadvances/article/1/1/36/15511/Extended-clinical-and-genetic-spectrum-associated
54. https://pubmed.ncbi.nlm.nih.gov/12676566/
55. https://academic.oup.com/nar/article/53/D1/D444/7905301
56. https://pmc.ncbi.nlm.nih.gov/articles/PMC9743508/
57. https://pmc.ncbi.nlm.nih.gov/articles/PMC12096892/
58. https://pmc.ncbi.nlm.nih.gov/articles/PMC29841/
59. https://www.nature.com/articles/s41467-024-46413-6